Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial

This publication has 20 references indexed in Scilit:

• The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis1
  Transplantation, 2003
• Tacrolimus in pediatric liver transplantation
  Pediatric Transplantation, 2002
• Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial
  The Lancet, 2002
• Epstein–Barr virus‐related lymphoproliferation in children after liver transplant: Role of immunity, diagnosis, and management
  Pediatric Transplantation, 2002
• Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
  European Journal of Drug Metabolism and Pharmacokinetics, 1998
• FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER TRANSPLANTATION
  Transplantation, 1995
• AN INCREASED INCIDENCE OF EPSTEIN-BARR VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG CHILDREN ON FK506 AFTER LIVER TRANSPLANTATION1
  Transplantation, 1995
• A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation
  New England Journal of Medicine, 1994
• Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection
  The Lancet, 1994
• DIFFERENCES IN ORAL FK506 DOSE REQUIREMENTS BETWEEN ADULT AND PEDIATRIC LIVER TRANSPLANT PATIENTS
  Transplantation, 1993